Crossmark

Process evaluation of a randomised controlled trial - prevention of sickness absence through early identification and rehabilitation of at-risk patients with musculoskeletal disorders (PREVSAM)

Crossref DOI link: https://doi.org/10.1186/s12913-024-11758-7

Published Online: 2024-10-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ekhammar, Annika https://orcid.org/0009-0003-5619-9055
Larsson, Maria EH https://orcid.org/0000-0002-1225-9736
Samsson, Karin https://orcid.org/0000-0002-8392-2021
Bernhardsson, Susanne https://orcid.org/0000-0001-8212-7678
Funding

Funding for this research was provided by:

University of Gothenburg
License Information

Text and Data Mining valid from 2024-10-26

Version of Record valid from 2024-10-26
More Information

Article History

Received: 23 May 2024

Accepted: 14 October 2024

First Online: 26 October 2024

Declarations

:

: All studies within the PREVSAM project were approved by the Swedish Ethical Review Authority (Registration no. 2019 − 00832/1253-18, amendments 2020 − 00417, 2021–02204, 2021–04275, 2022-06191-02, 2023 − 00859, 2024-02233-02). Written informed consent was obtained from all participants.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below